Baebies, Inc.

Baebies is a medical device company that develops and commercializes diagnostic technology powered by digital microfluidics. Its flagship product, the FINDER platform, is a compact, multifunctional diagnostic system that performs molecular, immunoassay, chemistry, and coagulation testing on a single unit. By utilizing electrowetting droplet operations, the system can process small-volume samples to deliver rapid results, effectively integrating capabilities that traditionally required multiple specialized instruments. This technology is designed to be highly versatile, allowing for scalable assay development and near-patient implementation in various clinical settings.

The company's technology is critical for healthcare providers, including urgent care centers, emergency departments, and clinics, by enabling faster diagnostic decision-making during a single patient visit. By providing lab-equivalent performance in a small footprint, Baebies aims to decentralize testing and improve access to diagnostic care. Founded in 2013 and headquartered in Research Triangle Park, North Carolina, the company has transitioned from an initial focus on newborn screening to a broader vision of providing rapid, multifunctional diagnostics for patients of all ages, supported by an extensive portfolio of global patents.